Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

650
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
650
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

338
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
338

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disease course, survival, and genetic heterogeneity in chorea-acanthocytosis: a case series of 34 patients.

Journal of movement disorders·2026
Same author

Effect of a continuous care model-based program on fatigue, self-efficacy, and quality of life in patients with Parkinson's disease: study protocol for a randomized controlled trial.

Trials·2025
Same author

A report of the Iranian Parkinson's disease registry.

NPJ Parkinson's disease·2025
Same author

The Effect of Multimodal Exercise on the Levels of BDNF and GDNF in Patients with Parkinson's Disease.

International journal of preventive medicine·2025
Same author

The Footprint of <i>CHASERR</i> as a Potential Culprit in Alzheimer's Disease Patients: An <i>In-Silico</i>-Experimental Study.

Current Alzheimer research·2025
Same author

Cervical extraosseous Ewing's sarcoma: A case report.

Radiology case reports·2025

Related Experiment Video

Updated: Aug 16, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.3K

Establishing a minimum data set for Parkinson's (PMDS) in Iran.

Ahmad Chitsaz1, Sima Ajami2, Maryam Varnaseri3

  • 1Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Hezarjerib Avenue, Isfahan, Iran.

Journal of Education and Health Promotion
|December 26, 2022
PubMed
Summary

A national Parkinson's Minimum Data Set (PMDS) was established in Iran to standardize data collection for Parkinson's disease patients. This comprehensive PMDS includes 223 data elements across administrative and clinical categories.

Keywords:
Information systemsParkinsonminimum data setregistry

More Related Videos

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.7K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

7.9K

Related Experiment Videos

Last Updated: Aug 16, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.3K
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.7K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

7.9K

Area of Science:

  • Health Informatics
  • Neurology
  • Data Management

Background:

  • The development of health care information systems relies on Minimum Data Sets (MDS).
  • Iran currently lacks a centralized national registry and a specific Parkinson's Minimum Data Set (PMDS).

Purpose of the Study:

  • To establish a national Parkinson's Minimum Data Set (PMDS) for Iran.
  • To standardize the collection of data for Parkinson's disease patients within the country.

Main Methods:

  • A descriptive-comparative study was conducted between 2019-2021.
  • Data elements were identified from Iran and selected countries, then categorized.
  • A draft PMDS was developed and validated by 50 healthcare professionals using the Delphi technique.

Main Results:

  • The established PMDS comprises 223 data elements.
  • These elements are divided into administrative (72 elements, 10 subcategories) and clinical (151 elements, 14 subcategories) categories.
  • The Delphi technique confirmed the validity of the finalized PMDS.

Conclusions:

  • Establishing an MDS is crucial for national data collection standardization.
  • The newly created PMDS is essential for systematically collecting data on Parkinson's patients in Iran.